Sintx Technologies, Inc. (NASDAQ:SINT) Sees Large Drop in Short Interest

Sintx Technologies, Inc. (NASDAQ:SINT) saw a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 199,913 shares, a decrease of 21.8% from the March 31st total of 255,636 shares. Approximately 5.1% of the shares of the company are sold short. Based on an average trading volume of 30,918 shares, the days-to-cover ratio is presently 6.5 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC lifted its position in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 33.5% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 15,339 shares of the company’s stock after buying an additional 3,848 shares during the quarter. Geode Capital Management LLC owned approximately 0.56% of Sintx Technologies worth $49,000 at the end of the most recent quarter. Institutional investors own 18.38% of the company’s stock.

Sintx Technologies Price Performance

NASDAQ:SINT opened at $2.13 on Wednesday. Sintx Technologies has a one year low of $2.09 and a one year high of $6.78. The business has a fifty day moving average price of $2.69 and a 200-day moving average price of $3.24. The firm has a market capitalization of $8.78 million, a price-to-earnings ratio of -0.38 and a beta of 0.66.

Wall Street Analyst Weigh In

Several research analysts have issued reports on SINT shares. HC Wainwright began coverage on Sintx Technologies in a research report on Monday, April 13th. They issued a “buy” rating and a $10.00 target price on the stock. Ascendiant Capital Markets lowered their price objective on shares of Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a report on Tuesday, April 21st. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $11.00.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.